-
1
-
-
84879327902
-
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
-
Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1, e00049 (2012).
-
(2012)
Elife
, vol.1
, pp. e00049
-
-
Yan, H.1
-
2
-
-
84894230843
-
Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide
-
Yan, H. et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J. Virol. 6, 3273-3284 (2014).
-
(2014)
J. Virol.
, vol.6
, pp. 3273-3284
-
-
Yan, H.1
-
3
-
-
84899486063
-
Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
-
Watashi, K. et al. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). Hepatology 59, 1726-1737 (2014).
-
(2014)
Hepatology
, vol.59
, pp. 1726-1737
-
-
Watashi, K.1
-
4
-
-
84894237342
-
Hepatitis B and D viruses exploit sodium taurocholate co-Transporting polypeptide for species-specific entry into hepatocytes
-
Ni, Y. et al. Hepatitis B and D viruses exploit sodium taurocholate co-Transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146, 1070-1083 (2014).
-
(2014)
Gastroenterology
, vol.146
, pp. 1070-1083
-
-
Ni, Y.1
-
5
-
-
84902973225
-
Strategies to inhibit entry of HBV and HDV into hepatocytes
-
Urban, S., Bartenschlager, R., Kubitz, R., & Zoulim, F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology 147, 48-64 (2014).
-
(2014)
Gastroenterology
, vol.147
, pp. 48-64
-
-
Urban, S.1
Bartenschlager, R.2
Kubitz, R.3
Zoulim, F.4
-
6
-
-
0028047191
-
Hepatitis B virus persistence after recovery from acute viral hepatitis
-
Michalak, T. I., Pasquinelli, C., Guilhot, S., & Chisari, F. V. Hepatitis B virus persistence after recovery from acute viral hepatitis. J. Clin. Invest. 93, 230-239 (1994).
-
(1994)
J. Clin. Invest.
, vol.93
, pp. 230-239
-
-
Michalak, T.I.1
Pasquinelli, C.2
Guilhot, S.3
Chisari, F.V.4
-
7
-
-
0035804282
-
Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab
-
Dervite, I., Hober, D., & Morel, P. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N. Engl. J. Med. 344, 68-69 (2001).
-
(2001)
N. Engl. J. Med.
, vol.344
, pp. 68-69
-
-
Dervite, I.1
Hober, D.2
Morel, P.3
-
8
-
-
79551543248
-
Rituximab-Associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: Meta-Analysis and examination of FDA safety reports
-
Evens, A. M. et al. Rituximab-Associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-Analysis and examination of FDA safety reports. Ann. Oncol. 22, 1170-1180 (2011).
-
(2011)
Ann. Oncol.
, vol.22
, pp. 1170-1180
-
-
Evens, A.M.1
-
9
-
-
84901591515
-
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
-
Hsu, C. et al. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology 59, 2092-2100 (2014).
-
(2014)
Hepatology
, vol.59
, pp. 2092-2100
-
-
Hsu, C.1
-
10
-
-
84911424291
-
Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: A prospective study
-
Seto, W. K. et al. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study. J. Clin. Oncol. 32, 3736-3743 (2014).
-
(2014)
J. Clin. Oncol.
, vol.32
, pp. 3736-3743
-
-
Seto, W.K.1
|